PropertyValue
?:abstract
  • A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis populations, the findings should be interpreted with caution.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1038/s41581-020-00379-y
?:journal
  • Nat_Rev_Nephrol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/f5d22b160c9b49a363017f2bf246585edd9e4fdb.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7682124.xml.json
?:pmcid
?:pmid
?:pmid
  • 33230249.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • The seroprevalence of SARS-CoV-2 in patients on haemodialysis
?:type
?:year
  • 2020-11-23

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/jn58r3me>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/jn58r3me>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all